Under this partnership, Haver Farma has secured the exclusive rights for the registration and commercialization of two products within the oncology and urology therapeutic areas in Türkiye.
This collaboration brings together AMW’s expertise in the development and manufacturing of innovative drug delivery systems with Haver Farma’s more than a century of pharmaceutical experience and strong presence in the Turkish hospital market. We believe this partnership represents an important addition to our growing portfolio and the beginning of a promising relationship between our companies.
We are very excited to work closely with the AMW team on this project and look forward to exploring further opportunities for cooperation and expanding our partnership through potential future projects.
